Abstract
Background: Liberal oxygen supplementation is often used in acute illness but has, in some studies, been associated with harm. Research Question: The goal of this study was to assess the benefits and harms of higher vs lower oxygenation strategies in acutely ill adults. Study Design and Methods: This study was an updated systematic review with meta-analysis and Trial Sequential Analysis (TSA) of randomized clinical trials. A clear differentiation (separation) was made between a higher (liberal) oxygenation and a lower (conservative) oxygenation strategy and their effects on all-cause mortality, serious adverse events, quality of life, lung injury, sepsis, and cardiovascular events at time points closest to 90 days in acutely ill adults. Results: The study included 50 randomized clinical trials of 21,014 participants; 36 trials with a total of 20,166 participants contributed data to the analyses. Meta-analysis and TSAs showed no difference between higher and lower oxygenation strategies in trials at overall low risk of bias except for blinding: mortality relative risk (RR), 0.98 (95% CI, 0.89-1.09; TSA-adjusted CI, 0.86-1.12; low certainty evidence); serious adverse events RR, 0.99 (95% CI, 0.89-1.12; TSA-adjusted CI, 0.83-1.19; low certainty evidence). The corresponding summary estimates including trials with overall low and high risk of bias showed similar results. No difference was found between higher and lower oxygenation strategies in meta-analyses and TSAs regarding quality of life, lung injury, sepsis, and cardiovascular events (very low certainty evidence). Interpretation: No evidence was found of beneficial or harmful effects of higher vs lower oxygenation strategies in acutely ill adults (low to very low certainty evidence). Clinical Trial Registration: PROSPERO; No.: CRD42017058011; URL: https://www.crd.york.ac.uk/prospero/.
| Original language | English |
|---|---|
| Journal | Chest |
| Volume | 159 |
| Issue number | 1 |
| Pages (from-to) | 154-173 |
| Number of pages | 20 |
| ISSN | 0012-3692 |
| DOIs | |
| Publication status | Published - 2021 |
Funding
FUNDING/SUPPORT: The contributions of M. B. and O.L. S. to this work were supported by Innovation fund Denmark [Grant 4108-00011B]. Financial/nonfinancial disclosures: The authors have reported to CHEST the following: O. L. S. is a member of the Management Committee of the Handling Oxygenation Targets in the Intensive Care Unit (HOT-ICU) trial, investigating higher vs lower oxygenation targets in patients admitted to the ICU (NCT03174002). C. S. M. reports direct and indirect departmental research funding from Ferring Pharmaceuticals , Radiometer, Merck , Sharp & Dohme Corp., and Boehringer Ingelheim as well as lecture fees from Radiometer outside the submitted work. C. S. M. was the principal investigator of the Perioperative Oxygen Fraction–Effect on Surgical Site Infection and Pulmonary Complications After Abdominal Surgery (PROXI) trial investigating higher vs lower levels of perioperative inspiratory oxygen; he is also a principal site investigator of the HOT-ICU trial and sponsor for the VIXIE trial investigating perioperative inspiratory oxygen (NCT03494387). B. S. R. is the sponsor and primary investigator of the HOT-ICU trial. A. P. is a member of the Management Committee of the HOT-ICU trial. J. W. is a member of the task at Copenhagen Trial Unit to develop theory and software for performing TSA available as freeware (including a comprehensive manual at www.ctu/tsa ) and a member of the Management Committee of the HOT-ICU trial. None declared (M. B., S. R. K., J. C. J.).
Keywords
- critical care
- meta-analysis
- mortality
- oxygen
- systematic review
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS